Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial

Priyanka Raheja; Niamh O'Connell; Peter Verhamme; Peter Kampmann; Richard S. Lemons; Fei Wang; Paul E Monahan; Sandra Le Quellec; Frank W.G.  Leebeek

Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial

Priyanka Raheja, Niamh O'Connell, Peter Verhamme, Peter Kampmann, Richard S. Lemons, Fei Wang, Paul E Monahan, Sandra Le Quellec, Frank W.G. Leebeek

Department of Haematology

15 Downloads (Pure)

Original language	English
Publication date	2025
Publication status	Published - 2025
Event	18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting - Milano, Italy Duration: 4 Feb 2025 → 7 Feb 2025 Conference number: 18 https://eahadcongress.com/

Conference

Conference	18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting
Number	18
Country/Territory	Italy
City	Milano
Period	04/02/2025 → 07/02/2025
Internet address	https://eahadcongress.com/

Access to Document

Raheja_PO040_EAHAD 2025_HGX NAb-negative_Final_29Jan2025

Cite this

Raheja, P., O'Connell, N., Verhamme, P., Kampmann, P., Lemons, R. S., Wang, F., Monahan, P. E., Le Quellec, S., & Leebeek, F. W. G. (2025). Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial. Poster session presented at 18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting, Milano, Italy.

Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial. / Raheja, Priyanka; O'Connell, Niamh; Verhamme, Peter et al.
2025. Poster session presented at 18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting, Milano, Italy.

Research output: Contribution to conference › Poster › Research

Raheja, P, O'Connell, N, Verhamme, P, Kampmann, P, Lemons, RS, Wang, F, Monahan, PE, Le Quellec, S & Leebeek, FWG 2025, 'Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial', 18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting, Milano, Italy, 04/02/2025 - 07/02/2025.

@conference{e6e62404aa8d4a398e12440391aa00e0,

title = "Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial",

author = "Priyanka Raheja and Niamh O'Connell and Peter Verhamme and Peter Kampmann and Lemons, \{Richard S.\} and Fei Wang and Monahan, \{Paul E\} and \{Le Quellec\}, Sandra and Leebeek, \{Frank W.G.\}",

year = "2025",

language = "English",

note = "18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting ; Conference date: 04-02-2025 Through 07-02-2025",

url = "https://eahadcongress.com/",

}

TY - CONF

T1 - Four-year results of etranacogene dezaparvovec in haemophilia B patients without pre-existing AAV5 neutralising antibodies: Phase 3 HOPE-B trial

AU - Raheja, Priyanka

AU - O'Connell, Niamh

AU - Verhamme, Peter

AU - Kampmann, Peter

AU - Lemons, Richard S.

AU - Wang, Fei

AU - Monahan, Paul E

AU - Le Quellec, Sandra

AU - Leebeek, Frank W.G.

N1 - Conference code: 18

PY - 2025

Y1 - 2025

M3 - Poster

T2 - 18th Annual Congress of the European Association for Haemophilia and Allied Disorders meeting

Y2 - 4 February 2025 through 7 February 2025

ER -